
Adrienne Rivlin, Partner, L.E.K. Consulting
Advertisement

Dr. Adrienne Rivlin is a partner in L.E.K.’s Healthcare practice, based in the London office. She advises private and public sector organisations across the pharmaceutical, biotech, medical device and consumer healthcare sectors on their critical commercial challenges, including corporate and portfolio strategy development; product launch; pricing and market access; clinical governance structures and processes; and commercial and regulatory due diligence.
Email: a.rivlin@lek.com
Articles by Adrienne Rivlin, Partner, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Redefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdink
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Additive Manufacturing's Application in Pharma and Biotech
4
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
5